Cargando…

Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification

Detalles Bibliográficos
Autores principales:	Falcone, Marco, Tiseo, Giusy, Menichetti, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869783/ https://www.ncbi.nlm.nih.gov/pubmed/33522876 http://dx.doi.org/10.1513/AnnalsATS.202009-1207ED

Ejemplares similares

Management of COVID patients with convalescent plasma: Do we have the final word?
por: Menichetti, Francesco, et al.
Publicado: (2022)

Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy
por: Falcone, Marco, et al.
Publicado: (2020)

Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment
por: Russo, Alessandro, et al.
Publicado: (2020)

Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020
por: Falcone, Marco, et al.
Publicado: (2020)

Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae–Producing KPC-31, a D179Y Variant of KPC-3
por: Tiseo, Giusy, et al.
Publicado: (2021)

Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset Pneumonia
por: Falcone, Marco, et al.
Publicado: (2015)

Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae
por: Falcone, Marco, et al.
Publicado: (2020)

1650. Efficacy of β-Lactam Therapy against Infections Caused by Metallo-β-lactamase (MBL)-Producing Enterobacterales: Bridging the Susceptibility Testing Gap
por: Abdelraouf, Kamilia, et al.
Publicado: (2022)

Skin and soft tissue infections in the elderly
por: Falcone, Marco, et al.
Publicado: (2023)

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
por: Amati, Francesco, et al.
Publicado: (2023)

Research in community-acquired pneumonia: the next steps
por: Torres, Antoni, et al.
Publicado: (2017)

Caring for older adults during the COVID-19 pandemic
por: Prendki, Virginie, et al.
Publicado: (2022)

What is the clinical significance of ‘heteroresistance’ in nonfermenting Gram-negative strains?
por: Tiseo, Giusy, et al.
Publicado: (2023)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2018)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

PNEUMONIA | Community Acquired Pneumonia, Bacterial and Other Common Pathogens
por: Niederman, M.S.
Publicado: (2006)

C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study
por: Nieri, Dario, et al.
Publicado: (2021)

Predictors and outcomes of respiratory bacterial coinfections in patients with COVID‐19 admitted to hospital: An observational prospective study
por: Tiseo, Giusy, et al.
Publicado: (2022)

Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study
por: Falcone, Marco, et al.
Publicado: (2020)

Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19
por: Falcone, Marco, et al.
Publicado: (2022)

Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2018)

A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea
por: Son, Young Woong, et al.
Publicado: (2017)

Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia
por: Idigo, Adeniyi J., et al.
Publicado: (2022)

Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
por: Gadsby, Naomi J., et al.
Publicado: (2016)

Diagnosing Viral and Atypical Pathogens in the Setting of Community-Acquired Pneumonia
por: Waterer, Grant W.
Publicado: (2017)

Pathogen spectra in hospitalised and nonhospitalised children with community-acquired pneumonia
por: Wetzke, Martin, et al.
Publicado: (2023)

Diagnosis of Multidrug-Resistant Pathogens of Pneumonia
por: Sfeir, Maroun M.
Publicado: (2021)

Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2020)

Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern
por: Falcone, Marco, et al.
Publicado: (2021)

Regenerative medicine owes to microsurgery
por: Shirbache, Kamran, et al.
Publicado: (2023)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Community-acquired pneumonia
por: File, Thomas M
Publicado: (2003)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Community Acquired Pneumonia
por: Wunderink, Richard G., et al.
Publicado: (2016)

Community-Acquired Pneumonia
por: Boza Costagliola, María Lina
Publicado: (2020)

Community Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2019)

Community-Acquired Pneumonia
por: Rider, Ashley C., et al.
Publicado: (2018)

Community-acquired pneumonia
por: Niederman, Michael S.
Publicado: (2010)

Community-Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5ff0isa0da00e5gc5at338c9hd